Napolitano Janet's Form 4 filing
Vir Biotechnology, Inc. (VIR) · filed Jun 2, 2025
- Accession no.
- 0001628280-25-028896
- Filed
- Jun 2, 2025
- Trade date
- May 30-Jun 2, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $16.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Napolitano JanetCIK 0001821008 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | AGrant or awardAcquired | +8,000 | $0.00 | $0 | 19,616 | Direct | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −3,200 | $5.05 | −$16,160 | 16,416 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | AGrant or awardAcquired | +16,000 | $0.00 | $0 | 16,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.